18 studies found for:    Open Studies | "Pyelonephritis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Pyelonephritis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Antibiotic Prophylaxis in Children With Pyelonephritis
Condition: Pyelonephritis
Interventions: Drug: Trimethoprim Sulfamethoxazole;   Drug: placebo
2 Recruiting Effect of Acetylcysteine in Pediatric Acute Pyelonephritis.
Condition: Pyelonephritis
Interventions: Drug: Acetylcysteine;   Drug: placebo acetylcysteine
3 Recruiting Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis
Conditions: Urinary Tract Infections;   Acute Pyelonephritis
Interventions: Drug: Finafloxacin 800 mg i.v. once daily;   Drug: Finafloxacin placebo i.v. once daily;   Drug: Finafloxacin 800 mg tablets (as four 200 mg tablets) once daily;   Drug: Finafloxacin placebo tablets (as four tablets) once daily;   Drug: Ciprofloxacin 400 mg i.v. two times daily;   Drug: Ciprofloxacin placebo i.v. two times daily;   Drug: Ciprofloxacin 500 mg oral (as two 250 mg capsules) two times daily;   Drug: Ciprofloxacin placebo oral (as two capsules each) two times daily
4 Recruiting Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Uncomplicated Pyelonephritis Due to Extended-spectrum β-lactamase Producing Escherichia Coli
Condition: Uncomplicated Pyelonephritis Due to ESBL-producing E.Coli
Intervention: Drug: Cefoxitin
5 Recruiting Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis
Condition: Pyelonephritis
Intervention: Other: No intervention
6 Recruiting L-carnitine on the Prevention of Renal Scarring in Acute Pyelonephritis
Condition: Acute Pyelonephritis(APN)
Intervention: Drug: L-carnitine
7 Recruiting Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in Children
Condition: Acute Pyelonephritis(APN)
Intervention: Drug: Omega-3
8 Not yet recruiting Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication
Conditions: Ankle Sprain;   Infectious Colitis;   Diverticulitis;   Pyelonephritis;   Prostatitis;   Pneumonitis
Intervention: Procedure: Patient Information Leaflet (PIL)
9 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Anesthesia;   Pain;   Reflux;   Nausea;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure)
Intervention: Drug: Ampicillin
10 Recruiting Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection
Condition: Acute Pyelonephritis
Intervention:
11 Unknown  Contrast-Enhanced US of Spleen, Liver and Kidney
Conditions: Malaria;   Pyelonephritis;   Bacterial Infections
Intervention:
12 Recruiting Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
Conditions: Urinary Tract Infections;   Pyelonephritis
Interventions: Drug: MK-7655 250 mg;   Drug: MK-7655 125 mg;   Drug: imipenem/cilastatin 500 mg;   Drug: Placebo to MK-7655;   Drug: Ciprofloxacin
13 Recruiting Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Children
Conditions: Urinary Tract Infection;   Pyelonephritis;   Cystitis
Intervention: Other: Cranberry-lingonberry juice
14 Not yet recruiting Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria
Conditions: Asymptomatic Bacteriuria;   Pyelonephritis
Interventions: Drug: Antibiotic treatment;   Other: No treatment
15 Recruiting Efficacy, Safety, Tolerability of Carbavance Compared to Piperacillin/Tazobactam in cUTIs, Including AP, in Adults
Conditions: Urinary Tract Infection Complicated;   Acute Pyelonephritis
Interventions: Drug: Carbavance;   Drug: Piperacillin/tazobactam;   Drug: Levofloxacin oral
16 Recruiting Efficacy, Safety, Tolerability of Carbavance Compared to Best Available Therapy in Serious Infections Due to Carbapenem Resistant Enterobacteriaceae, in Adults
Conditions: Urinary Tract Infection Complicated;   Acute Pyelonephritis;   Hospital Acquired Bacterial Pneumonia;   Ventilator-associated Bacterial Pneumonia;   Bacteremia
Interventions: Drug: Carbavance;   Drug: Best Available Therapy
17 Unknown  Urinary Cytokine Levels as a Prognostic Marker for Kidney Scarring After Pyelonephritis
Condition: Kidney Scarring Post-Febrile UTI
Intervention:
18 Unknown  Febrile Urinary Tract Infection Randomized Short Treatment Trial
Condition: Urinary Tract Infection
Intervention: Drug: short treatment (ciprofloxacin)

Indicates status has not been verified in more than two years